Publications by the researcher in collaboration with Mª Isabel Fernández Pisonero (13)

2023

  1. Characterization of mutant versions of the R-RAS2/TC21 GTPase found in tumors

    Oncogene, Vol. 42, Núm. 5, pp. 389-405

2022

  1. A hotspot mutation targeting the R-RAS2 GTPase acts as a potent oncogenic driver in a wide spectrum of tumors

    Cell Reports, Vol. 38, Núm. 11

  2. Characterization of the spectrum of trivalent VAV1-mutation-driven tumours using a gene-edited mouse model

    Molecular Oncology, Vol. 16, Núm. 19, pp. 3533-3553

  3. Overexpression of wild type RRAS2, without oncogenic mutations, drives chronic lymphocytic leukemia

    Molecular Cancer, Vol. 21, Núm. 1

2021

  1. Cancer-associated mutations in VAV1 trigger variegated signaling outputs and T-cell lymphomagenesis

    EMBO Journal, Vol. 40, Núm. 22

  2. Distinct roles of vav family members in adaptive and innate immune models of arthritis

    Biomedicines, Vol. 9, Núm. 6

2020

  1. Rho guanosine nucleotide exchange factors are not such bad guys after all in cancera

    Small GTPases, Vol. 11, Núm. 4, pp. 233-239

  2. Vav2 catalysis-dependent pathways contribute to skeletal muscle growth and metabolic homeostasis

    Nature Communications, Vol. 11, Núm. 1

2019

  1. Vav proteins maintain epithelial traits in breast cancer cells using miR-200c-dependent and independent mechanisms

    Oncogene, Vol. 38, Núm. 2, pp. 209-227

2018

  1. An unexpected tumor suppressor role for VAV1a

    Molecular and Cellular Oncology, Vol. 5, Núm. 3

  2. R-Ras2 is required for germinal center formation to aid B cells during energetically demanding processes

    Science Signaling, Vol. 11, Núm. 532

  3. RAS GTPase-dependent pathways in developmental diseases: old guys, new lads, and current challenges

    Current Opinion in Cell Biology, Vol. 55, pp. 42-51

2017

  1. A Paradoxical Tumor-Suppressor Role for the Rac1 Exchange Factor Vav1 in T Cell Acute Lymphoblastic Leukemia

    Cancer Cell, Vol. 32, Núm. 5, pp. 608-623.e9